The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis
Open accessAbstract
beta-Arrestins bind agonist-activated G protein-coupled receptors (GPCRs) and mediate their desensitization and internalization. Although beta-arrestins dissociate from some receptors at the plasma membrane, such as the beta2 adrenergic receptor, they remain associated with other GPCRs and internalize with them into endocytic vesicles. Formation of stable receptor-beta-arrestin complexes that persist inside the cell impedes receptor resensitization, and the aberrant formation of these complexes may play a role in GPCR-based diseases (Barak, L. S., Oakley, R. H., Laporte, S. A., and Caron, M. G. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 93-98). Here, we investigate the molecular determinants responsible for sustained receptor/beta-arrestin interactions. We show in real time and in live human embryonic kidney (HEK-293) cells that a beta-arrestin-2-green fluorescent protein conjugate internalizes into endocytic vesicles with agonist-activated neurotensin-1 receptor, oxytocin receptor, angiotensin II type 1A receptor, and substance P receptor. Using receptor mutagenesis, we demonstrate that the ability of beta-arrestin to remain associated with these receptors is mediated by specific clusters of serine and threonine residues located in the receptor carboxyl-terminal tail. These clusters are remarkably conserved in their position within the carboxyl-terminal domain and serve as primary sites of agonist-dependent receptor phosphorylation. In addition, we identify a beta-arrestin mutant with enhanced affinity for the agonist-activated beta2-adrenergic receptor that traffics into endocytic vesicles with receptors that lack serine/threonine clusters and normally dissociate from wild-type beta-arrestin at the plasma membrane. By identifying receptor and beta-arrestin residues critical for the formation of stable receptor-beta-arrestin complexes, these studies provide novel targets for regulating GPCR responsiveness and treating diseases resulting from abnormal GPCR/beta-arrestin interactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, (Vargas-Pinilla et al., 2015) identified a new phosphorylation site in the OTR of Callithrix at R149S, and the shortening of a Ser cluster in the OTR of Saguinus that is important for β-arrestin mediated desensitization and receptor recycling (Innamorati et al., 1998; Oakley et al., 2001; Vargas-Pinilla et al., 2015).”
From Neuropeptide diversity and the regulation of social behavior in New World primates (2016) · cites this paper as Oakley et al., 2001
Citations
Cites
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S. R., Rocca, G. J. D., Lin, F., Kawakatsu, H., Owada, K. M., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,473
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,383
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,222
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,121
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,079
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 974
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
Parma, J., Duprez, L., SANDE, J. V., Cochaux, P., Gervy, C., Mockel, J., Dumont, J. E., & Vassart, G. (1993) · Nature · doi:10.1038/365649a0 · Cited by 914
Oakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G., & Barak, L. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910348199 · Cited by 882
DeFea, K., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 820
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
McDonald, P. H., Chow, C.-W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F., Davis, R. J., & Lefkowitz, R. J. (2000) · Science · doi:10.1126/science.290.5496.1574 · Cited by 818
Flagged first, then by citations
Research works printed but not linked: 1
- Roush, 1999, Mol. Pharmacol., 55, 855
Cited by
Sorted by citations
Items 201–300 of 456
Role of ßarrestins in bradykinin B2 receptor-mediated signalling
Zimmerman, B., Simaan, M., Akoume, M., Houri, N., Chevallier, S., Séguéla, P., & Laporte, S. A. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.016 · Cited by 39
Lecoq, I., Marie, N., Jauzac, P., & Allouche, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063958 · Cited by 39
“Partners of GPCR such as arrestins were identified as modulators of GPCR trafficking (Oakley et al., 1999, 2001) and could target the receptor to degradation.”
BackgroundKishi, H., Krishnamurthy, H., Galet, C., Bhaskaran, R. S., & Ascoli, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110894200 · Cited by 39
Pöll, F., Doll, C., & Schulz, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224899 · Cited by 38
Tang, H., Low, B., Rutherford, S. A., & Hao, Q. (2004) · Blood · doi:10.1182/blood-2004-08-3308 · Cited by 38
“The cytoplasmic domains of endoglin and its homologue betaglycan share a serine- and threonine-rich sequence (HSIGSTQSTPCS) that resembles β-arrestin-binding domain in GPCRs.(56) Thr-841 of betaglycan within the sequence has been shown to be For personal use only.”
BackgroundMolecular dissection of the human A 3 adenosine receptor coupling with β-arrestin2
Storme, J., Cannaert, A., Craenenbroeck, K. V., & Stove, C. P. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.008 · Cited by 36
QR code model: a new possibility for GPCR phosphorylation recognition
Chen, H., Zhang, S., Zhang, X., & Liu, H. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00832-4 · Cited by 37
“The function of the S/T cluster is to stabilize the binding between GPCRs and arrestin [98, 99] and to promote GPCRs to complete arrestin-clathrin-dependent endocytosis [100].”
BackgroundInternal PDZ Ligands: Novel Endocytic Recycling Motifs for G Protein-Coupled Receptors
Trejo, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011288 · Cited by 38
“It is known that arrestin binding to activated GPCRs involves phosphorylation-recognition sites and, in some cases, the stability of such interactions controls the kinetics of receptor recycling and resensitization (Oakley et al., 2001).”
BackgroundAmar, S., Shaltiel, G., Mann, L., Shamir, A., Dean, B., Scarr, E., Bersudsky, Y., Belmaker, R. H., & Agam, G. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007948 · Cited by 38
“Similarly to other G-protein coupled receptors prolonged activation of DRD2 results in ‘desensitization’ (Kim et al., 2001 ; Oakley et al., 2001).”
BackgroundNongenetic Bioconjugation Strategies for Modifying Cell Membranes and Membrane Proteins: A Review
Roy, S., Cha, J. N., & Goodwin, A. P. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00529 · Cited by 37
Arrestin3 mediates D2dopamine receptor internalization
Skinbjerg, M., Ariano, M. A., Thorsell, A., Heilig, M. A., Halldin, C., Innis, R. B., & Sibley, D. R. (2009) · Synapse · doi:10.1002/syn.20636 · Cited by 37
“Initial investigations by Oakley et al. (2000, 2001) suggested that there are two classes of GPCRs: Class A receptors, which bind arrestin3 with greater affinity than arrestin2, and Class B receptors which bind both arrestin2 and arrestin3 with high affinity.”
BackgroundMonitoring interactions between G-protein-coupled receptors and β-arrestins
Pfleger, K. D. G., Dalrymple, M. B., Dromey, J. R., & Eidne, K. A. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350764 · Cited by 36
Crudden, C., Ilic, M., Suleymanova, N., Worrall, C., Girnita, A., & Girnita, L. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.10.002 · Cited by 37
Galet, C., Hirakawa, T., & Ascoli, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0293 · Cited by 36
Balki, M., Ramachandran, N., Lee, S., & Talati, C. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001268 · Cited by 36
Lamian, V., Rich, A. J., Ma, Z., Li, J., Seethala, R., Gordon, D., & Dubaquié, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017111 · Cited by 36
“The amino acid sequence of the motilin receptor C-terminal tail does not seem to contain distinct S/T clusters, as described by Oakley et al. (2001).”
BackgroundG protein-independent cell-based assays for drug discovery on seven-transmembrane receptors
Verkaar, F., van Rosmalen, J. W. G., Blomenröhr, M., van Koppen, C. J., Blankesteijn, W. M., Smits, J. F. M., & Zaman, G. J. R. (2008) · Biotechnology annual review · doi:10.1016/s1387-2656(08)00010-0 · Cited by 35
The Influence of Maternal Body Mass Index on Myometrial Oxytocin Receptor Expression in Pregnancy
Grotegut, C. A., Gunatilake, R. P., Feng, L., Heine, R. P., & Murtha, A. P. (2013) · Reproductive Sciences · doi:10.1177/1933719113488446 · Cited by 34
“Oxytocin binds the OXTR at the plasma membrane, after which, a member of the G protein-coupled receptor kinase family phosphorylates an internal domain of the receptor, allowing for beta-arrestin recruitment to the receptor and receptor internalization and desensitization.(15) The receptor then recycles back to the pl…”
BackgroundPost-translational modifications of S1PR1 and endothelial barrier regulation
Anwar, M., & Mehta, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158760 · Cited by 34
Toy-Miou-Leong, M., Llorens‐Cortés, C., Beaudet, A., Rostène, W. H., & Forgez, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m303384200 · Cited by 33
Law, I. K. M., Murphy, J. E., Bakirtzi, K., Bunnett, N. W., & Pothoulakis, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327262 · Cited by 32
“1), confirming previous evidence in nonintestinal cells that NTR1 is a class B GPCR (21, 22).”
BackgroundInfluentialMORSHED, S. A., Ma, R., Latif, R., & Davies, T. F. (2018) · Science Signaling · doi:10.1126/scisignal.aah4120 · Cited by 32
“A repertoire of proteins is involved in the manufacture of endosomes and the maintenance of their functions (63).”
BackgroundBrighton, P. J., Rana, S., Challiss, R. A. J., Konje, J. C., & Willets, J. M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01173.x · Cited by 31
“…also demonstrate an agonist- and GRK-dependent interaction of recombinant oxytocin receptors and arrestin3 in HEK293/ COS-7 cell backgrounds (Oakley et al., 2001; Hasbi et al., 2004; Smith et al., 2006), with one study pinpointing two C-terminal Ser-Ser-Ser (368–370/377–379) clusters as the…”
BackgroundInfluentialBaidya, M., Kumari, P., Dwivedi‐Agnihotri, H., Pandey, S., Sokrat, B., Sposini, S., Chaturvedi, M., Srivastava, A., Roy, D., Hanyaloglu, A. C., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013470 · Cited by 30
“Engineering V2R tail typically imparts “class B” pattern on GPCRs and thereby, makes the detection of βarr1 interaction more robust compared to the unmodified receptors (29).”
BackgroundReceptor-mediated tumor targeting with radiopeptides
Eberlé, A. N., & Mild, G. (2009) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890902732823 · Cited by 31
“It is particularly advantageous when the targeted receptor belongs to the class B receptors known to rapidly undergo -arrestin-mediated internalization (158), as shown for the SRIF receptor sst 2A ; this enhances radioligand accumulation in the target cells.”
BackgroundKinetics of G-protein-coupled receptor signalling and desensitization
Krasel, C., Vilardaga, J., Bünemann, M., & Lohse, M. J. (2004) · Biochemical Society Transactions · doi:10.1042/bst0321029 · Cited by 31
Acharjee, S., Maiti, K., Soh, J. M., Im, W., Seong, J. Y., & Kwon, H. B. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15079-5 · Cited by 31
Unraveling allostery within the angiotensin II type 1 receptor for Gα q and β-arrestin coupling
Cao, Y., van der Velden, W. J. C., Namkung, Y., Nivedha, A. K., Cho, A., Sedki, D., Holleran, B. J., Lee, N. H., Leduc, R., Muk, S., et al. (2023) · Science Signaling · doi:10.1126/scisignal.adf2173 · Cited by 30
“T332 is phosphorylated after agonist stimulation of AT1R (27), and the T332A mutation decreased both the Emax and RA for βarrestin recruitment without significantly affecting AT1R coupling to Gαq.”
Shu, J., Zhang, F., Zhang, L., & Wei, W. (2016) · Inflammation Research · doi:10.1007/s00011-016-1011-5 · Cited by 30
“Aberrant formation of these complexes may play a role in GPCR-based diseases [84].”
BackgroundAdaptor Protein‐2 Interaction with Arrestin Regulates GPCR Recycling and Apoptosis
Wagener, B. M., Marjon, N. A., Revankar, C. M., & Prossnitz, E. R. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00957.x · Cited by 30
“Greater than 90% of GFP vector- and arr2(1-382)-expressing cells were PI positive upon ligand [N-formyl-methionyl-leucylphenylalanine (fMLF)] stimulation (Figure 1B), consistent with cell rounding results (Figure 1A).”
BackgroundMethodResultInfluentialCastel, H., Desrues, L., Joubert, J., Tonon, M., Prézeau, L., Chabbert, M., Morin, F., & Gandolfo, P. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00076 · Cited by 30
“Other specific motifs are observed, namely (i) a KRARR nuclear localization motif at the i3 loop (69), (ii) potential sites of phosphorylation by protein kinases A and C, kinase I, and glycogen synthase kinase 3 at i2 and i3 loops (35, 68, 70), (iii) serine potential phosphorylation sites at the C-terminal end involve…”
BackgroundWang, F., Chen, X., Zhang, X., & Ma, L. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0496 · Cited by 30
Lee, J., Gonzalez-Hernandez, A. J., Kristt, M., Abreu, N., Roßmann, K., Arefin, A., Marx, D. C., Broichhagen, J., & Levitz, J. (2023) · Science Advances · doi:10.1126/sciadv.adi8076 · Cited by 29
“In contrast, “ class B ” GPCRs remain bound to β-arrs along the endocytic pathway ( 12 – 14 ).”
Palmitoylation of the TPβ isoform of the human thromboxane A2 receptor.
Reid, H. M., & Kinsella, B. T. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.001 · Cited by 29
Internalization and recycling properties of neurotensin receptors
Mazella, J., & Vincent, J. (2006) · Peptides · doi:10.1016/j.peptides.2006.02.012 · Cited by 29
Constitutive Desensitization: A New Paradigm for G Protein-Coupled Receptor Regulation
Barak, L. S., Wilbanks, A. M., & Caron, M. G. (2003) · Assay and Drug Development Technologies · doi:10.1089/15406580360545152 · Cited by 29
“19,20 Last, receptor resensitization requires that receptor-bound arrestin be removed so that the receptor can be dephosphorylated and returned to the plasma membrane.”
Distinct activation mechanisms of β-arrestin-1 revealed by 19F NMR spectroscopy
Zhai, R., Wang, Z., Chai, Z., Niu, X., Li, C., Jin, C., & Hu, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-43694-1 · Cited by 28
Roy, S. F., Roy, S. J., Pinard, S., Taillefer, L.-D., Rached, M., Parent, J., & Gallo‐Payet, N. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0018 · Cited by 28
Remodeling our concept of chemokine receptor function: From monomers to oligomers
Martínez‐Muñoz, L., Villares, R., Rodríguez‐Fernández, J. L., Rodrı́guez-Frade, J. M., & Mellado, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr1217-503r · Cited by 28
Molecular mechanism of phosphorylation-dependent arrestin activation
Ostermaier, M. K., Schertler, G. F. X., & Standfuss, J. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.07.006 · Cited by 28
“Similarly, neurotensin-1 receptor, oxytocin receptor, angiotensin II type 1A receptor and substance P receptor have conserved serine/ threonine cluster motifs 45, 38/47, 25/32 and 50 residues downstream the NPxxY motif [46].”
BackgroundBeta-Arrestin2 as a Competitor for GRK2 Interaction with the GLP-1 Receptor upon Receptor Activation
Jørgensen, R., Roed, S. N., Heding, A., & Elling, C. (2011) · Pharmacology · doi:10.1159/000330742 · Cited by 27
Zindel, D., Butcher, A. J., Al‐Sabah, S., Lanzerstorfer, P., Weghuber, J., Tobin, A. B., Bünemann, M., & Krasel, C. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095422 · Cited by 27
“…the insertion of an additional cluster of serines into the C terminus of the b2AR 20 amino acids away from the membrane, as previously proposed by Oakley et al. (2001), can indeed enhance arrestin binding affinity to the receptor and alter arrestin trafficking without affecting other properties…”
BackgroundJørgensen, R., Holliday, N. D., Hansen, J. L., Vrecl, M., Heding, A., Schwartz, T. W., & Elling, C. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038877 · Cited by 27
“…tail C-terminal to the palmitoylated Cys is lacking (Richardson et al., 2003) The NK1R(1–324) variant (numbers referring to remaining amino acid residues) has been reported not to be phosphorylated and to have reduced ability to interact with arrs (Oakley et al., 2001; Richardson et al., 2003).”
BackgroundGlucagon receptor recycling: role of carboxyl terminus, β-arrestins, and cytoskeleton
Krilov, L., Nguyen, A., Miyazaki, T., Unson, C. G., & Bouscarel, B. E. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00240.2008 · Cited by 27
“In contrast, other studies have suggested that stable interactions with -arrestins abrogate receptor GPCR recycling (17).”
ResultGagnon, L., Cao, Y., Cho, A., Sedki, D., Huber, T., Sakmar, T. P., & Laporte, S. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010324 · Cited by 26
“As our search to understand how ligand-bound GPCRs lead to distinct conformations and -arr engagement and signaling continues, information gathered from the use of such approaches should inform structural, biophysical, and cell biological data.”
BackgroundInfluentialProtein phosphatase 2A mediates resensitization of the neurokinin 1 receptor
Murphy, J. E., Roosterman, D., Cottrell, G. S., Padilla, B. E., Feld, M., Brand, E., Cedron, W. J., Bunnett, N. W., & Steinhoff, M. S. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00096.2011 · Cited by 26
Fernández, N., Monczor, F., Baldi, A., Davio, C. A., & Shayo, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045336 · Cited by 26
“In this regard, it has been reported previously that the density of GPCR phosphorylation sites may be involved in regulating the stability of the interaction between the receptor and arrestin (Oakley et al., 2001).”
BackgroundJi, H., Liu, N., Li, J., Chen, D., Luo, D., Sun, Q., Liu, Y., Liu, Y., Bu, B., Chen, X., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz064 · Cited by 26
Gatfield, J., Monnier, L., Studer, R. O., Bolli, M. H., Steiner, B., & Nayler, O. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.029 · Cited by 26
Johnson, E. C., TIFT, F., McCauley, A. K., Liu, L.-Z., & Roman, G. (2008) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2008.09.003 · Cited by 25
“The molecular details by which the signals elicited by activation of G protein-coupled receptors (GPCRs) are attenuated involve a cohort of different regulatory proteins.”
InfluentialFrom membrane to nucleus: A three-wave hypothesis of cAMP signaling
Pizzoni, A., Zhang, X., & Altschuler, D. L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105497 · Cited by 23
“On the other hand, class B GPCRs exhibit higher af fi nity binding to β -arrestin, enabling prolonged Gs signaling from intracellular compartments (90, 91).”
BackgroundO’Keeffe, M. B., Reid, H. M., & Kinsella, B. T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.04.010 · Cited by 24
Hua, S., & Vaughan, B. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198116 · Cited by 24
“OTRs have previously been shown to congregate with β-arrestin following activation into defined punctuated regions of the plasma membrane, which suggest that they are targeted into clathrin-coated pits for internalization.(31,50) OTRs are also highly expressed in the cholesterol-rich, caveolin-containing membrane doma…”
BackgroundInhibition of Chemoattractant N‐Formyl Peptide Receptor Trafficking by Active Arrestins
Key, T. A., Vines, C. M., Wagener, B. M., Gurevich, V. V., Sklar, L. A., & Prossnitz, E. R. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00248.x · Cited by 24
“High agonist affinity complexes of arrestin-2–3A with phosphorylated forms of the FPR Arrestin-2 contains a series of consecutive amino acids in the carboxy-terminus with bulky, hydrophobic side chains (Ile386 Val387 Phe388).”
BackgroundPotter, R. M., Key, T. A., Gurevich, V. V., Sklar, L. A., & Prossnitz, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111086200 · Cited by 24
Mdm2-mediated ubiquitination of PKCβII in the nucleus mediates clathrin-mediated endocytic activity
Min, X., Zhang, X., Sun, N., Acharya, S., & Kim, K. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113675 · Cited by 23
3.1 Molecular Pharmacology of the Dopamine Receptors
Rankin, M. L., Hazelwood, L. A., Free, R. B., Namkung, Y., Rex, E., Roof, R. A., & Sibley, D. R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0006 · Cited by 25
Cavallaro, G., Maniscalco, L., Campisi, M., Schillaci, D., & Giammona, G. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.013 · Cited by 23
Receptor tyrosine kinase and G‐protein coupled receptor signaling and sorting within endosomes
Grimes, M. L., & Miettinen, H. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01603.x · Cited by 23
“…studies with V2R, AT1aR, neurotensin-1 receptor (NTR-1) and oxytocin receptor (OTR) indicate that the affinity of barr to these receptors is regulated by the cytoplasmic tail sequences, specifically within clusters of serine and threonine residues (SS, STS, SSS, SSXS) (Oakley et al. 2001).”
BackgroundForster, L., Grätz, L., Mönnich, D., Bernhardt, G., & Pockes, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176103 · Cited by 22
Cheng, S., & Filardo, E. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323782 · Cited by 22
Hattori, M., Tanaka, M., Takakura, H., Aoki, K., Miura, K., Anzai, T., & Ozawa, T. (2012) · Molecular BioSystems · doi:10.1039/c2mb25443c · Cited by 22
Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis
Morinelli, T. A., Luttrell, L. M., Strungs, E. G., & Ullian, M. E. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.04.016 · Cited by 22
“Not surprisingly then, GPCRs are the single most common target of drugs in clinical use (3).”
BackgroundInfluentialMagnan, R., Masri, B., Escrieut, C., Foucaud, M., Cordelier, P., & Fourmy, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.196048 · Cited by 22
Role of Rhodopsin and Arrestin Phosphorylation in Retinal Degeneration of Drosophila
Kristaponyte, I., Hong, Y., Lu, H., & Shieh, B. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0565-12.2012 · Cited by 22
Neuschäfer‐Rube, F., Hermosilla, R., REHWALD, M., Rönnstrand, L., Schülein, R., Wernstedt, C., & Püschel, G. P. (2004) · Biochemical Journal · doi:10.1042/bj20031820 · Cited by 22
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors
Tóth, A. D., Turu, G., & Hunyady, L. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00869-3 · Cited by 22
“The strength of the interaction between receptors and β-arrestins is mainly determined by the abundance of phosphorylated serine/ threonine-rich motifs in the C terminus or ICL3 region of the GPCR 46,47 .”
Discrete GPCR-triggered endocytic modes enable β-arrestins to flexibly regulate cell signaling
Barsi‐Rhyne, B., Manglik, A., & von Zastrow, M. (2022) · eLife · doi:10.7554/elife.81563 · Cited by 23
Molecular determinants of orexin receptor‐arrestin‐ubiquitin complex formation
Jaeger, W. C., Seeber, R. M., Eidne, K. A., & Pfleger, K. D. G. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12481 · Cited by 21
“Residues indicated in bold are in the serine/threonine (S/T) clusters that were assessed as putative GRK phosphorylation sites (Oakley et al., 2001).”
BackgroundInfluentialCell-type-specific pathways of neurotensin endocytosis
Savdie, C., Ferguson, S. S. G., Vincent, J., Beaudet, A., & Stroh, T. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-0102-3 · Cited by 25
“Accordingly, like other non-recycling receptors, NTS1 is internalized together with β–arrestin following stimulation with neurotensin (Zhang et al. 1999; Oakley et al. 2000, 2001).”
BackgroundInfluentialDepletion of β‐arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway
Sun, W., Song, Y., Hu, S., Wang, Q., Wu, H., Chen, J., & Wei, W. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24458 · Cited by 21
“Arrestins are known to promote receptor desensitization and internalization by interacting with the phosphorylated form of GPCRs, thereby preventing their coupling with G protein [Oakley et al., 2001; Liggett, 2011].”
BackgroundOakley, R. H., Hudson, C. C., Sjaastad, M. D., & Loomis, C. R. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)14004-5 · Cited by 21
Involvement of a cytoplasmic-tail serine cluster in urotensin II receptor internalization
Proulx, C. D., Simaan, M., Escher, E., Laporte, S. A., Guillemette, G., & Leduc, R. (2004) · Biochemical Journal · doi:10.1042/bj20040807 · Cited by 21
Kim, D. K., Yun, Y., Kim, H. R., Seo, M., & Chung, K. Y. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.04.006 · Cited by 20
Datta, N. S., Samra, T. A., Mahalingam, C. D., Datta, T., & Abou‐Samra, A. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0227 · Cited by 20
“…C-terminal serine and threonine residues of agonist-stimulated GPCRs and binding of the members of the b-arrestins (Pitcher et al. 1998, Oakley et al. 2001). b-Arrestin 1 and 2 knockout mice and transgenic mice with targeted overexpression of a peptide inhibitor of GRK2 have been used…”
Urs, N. M., Kowalczyk, A. P., & Radhakrishna, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m710003200 · Cited by 20
Hua, S. (2018) · Journal of Liposome Research · doi:10.1080/08982104.2018.1556293 · Cited by 19
Jacobs, C., Broeck, W. V. D., & Simoens, P. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.096 · Cited by 19
Kjær, V. M. S., Daugvilaite, V., Stępniewski, T. M., Madsen, C. M., Jørgensen, A. S., Bhuskute, K. R., Inoue, A., Ulven, T., Benned‐Jensen, T., Hjorth, S. A., et al. (2023) · Science Signaling · doi:10.1126/scisignal.abl4283 · Cited by 18
Zheng, M., Zhang, X., Guo, S., Zhang, X., Min, C., Cheon, S. H., Oak, M., Kim, Y. R., & Kim, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.007 · Cited by 18
Hauger, R. L., Olivares-Reyes, J. A., Braun, S. L., Hernández-Aranda, J., Hudson, C. C., Gutknecht, E., Dautzenberg, F. M., & Oakley, R. H. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.06.009 · Cited by 18
“dishes (MatTek, Ashland, MA) and cultured overnight using a previously published protocol [15,24].”
Grotegut, C. A., Ngan, E., Garrett, M. E., Miranda, M. L., Ashley‐Koch, A. E., & Swamy, G. K. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.05.023 · Cited by 18
“SEPTEMBER 2017 Ameri kinase 6 (GRK6), a member of the G proteinecoupled receptor kinase (GRK) family, allowing for the recruitment of barrestin, which leads to receptor internalization and desensitization.(9-12) As an entire class, GPCRs are prone to GRKmediated, b-arrestin-dependent desensitization.”
BackgroundBarak, L. S., Oakley, R. H., & Shetzline, M. A. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803322163722 · Cited by 18
“29 To determine if the kinetics of arrestin dissociation from the CCK-B receptor was similarly rapid, arrestin-GFP dissociation from gastrin-activated CCK-B receptors was measured after treatment with L-365,260 (Fig.”
β-Arrestin and Mdm2, Unsuspected Partners in Signaling from the Cell Surface
Strous, G. J., & Schantl, J. (2001) · Science s STKE · doi:10.1126/stke.2001.110.pe41 · Cited by 18
“shortly after endocytosis (27), allowing the resensitized receptor”
BackgroundNaturally Occurring Genetic Variants in the Oxytocin Receptor Alter Receptor Signaling Profiles
Malik, M., Ward, M. D., Fang, Y., Porter, J. R., Zimmerman, M. I., Koelblen, T., Roh, M., Frolova, A. I., Burris, T. P., Bowman, G. R., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00095 · Cited by 17
Functions of the Zinc-Sensing Receptor GPR39 in Regulating Intestinal Health in Animals
Xia, P.-P., Yan, L., Ji, X., Wu, Y., Lian, S.-Q., & Zhu, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012133 · Cited by 14
“In most cases, the first step in weakening the receptor response is mediated by the receptor-specific amino acid phosphorylation of GPCRs by GPCR kinases, especially serine and threonine at the carboxyl terminal of the receptor [35].”
BackgroundPunn, A., Chen, J., Delidaki, M., Tang, J., Liapakis, G., Lehnert, H., Levine, M. A., & Grammatopoulos, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.272161 · Cited by 17
β-Arrestin-Based Bret2 Screening Assay for the “Non”-β-Arrestin Binding CB1 Receptor
Vrecl, M., Nørregaard, P. K., Almholt, D. L. C., Elster, L., Pogačnik, A., & Heding, A. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109333101 · Cited by 17
“The V2R C-terminal tail was selected because its role in mediating the formation of stable receptor/β-arr complexes is well established.(17,19) In addition, the V2R has also been successfully used in the β-arrestin-based BRET(2) assay(28) as well as in the Transfluor arrestin recruitment assay.”
MethodFroemke, R. C., & Carcea, I. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00037-1 · Cited by 20
Souazé, F., & Forgez, P. (2006) · Peptides · doi:10.1016/j.peptides.2006.04.029 · Cited by 17
Maturation of respiratory control in the behaving mammal
Moss, I. R. (2002) · Respiratory Physiology & Neurobiology · doi:10.1016/s1569-9048(02)00070-8 · Cited by 17
Eberlé, A. N., Mild, G., & Froidevaux, S. (2004) · Journal of Receptors and Signal Transduction · doi:10.1081/rrs-200040939 · Cited by 17
Lukashova, V., Szabó, E. Z., Jinadasa, T., Mokhov, A., Litchfield, D. W., & Orlowski, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182881 · Cited by 16
Marazziti, D., Diep, P.-T., Carter, C. S., & Carbone, M. G. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220727120646 · Cited by 16
Kim, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076742 · Cited by 15
“This ability of arrestins to remain associated with class B receptors is facilitated by specific clusters of serine and threonine residues located in the carboxyl-terminal tails of the receptors [66].”
BackgroundBudzinski, J., Maschauer, S., Kobayashi, H., Couvineau, P., Vogt, H., Gmeiner, P., Roggenhofer, A., Prante, O., Bouvier, M., & Weikert, D. (2021) · Communications Biology · doi:10.1038/s42003-021-02574-4 · Cited by 15
Wofford, W. O., Kim, J., Kim, D., Janneh, A. H., Lee, H. G., Atilgan, F. C., Oleinik, N. V., Kassir, M. F., Saatci, Ö., Chakraborty, P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114532 · Cited by 15
“24– 26 Sphingolipids play structural roles in regulating the rigidity and shape of the plasma membrane.”
Grotegut, C. A., Mao, L., Pierce, S., Swamy, G. K., Heine, R. P., & Murtha, A. P. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1147 · Cited by 15
Intracellular Trafficking of Gonadotropin Receptors in Health and Disease
Ulloa‐Aguirre, A., Zariñán, T., Gutiérrez‐Sagal, R., & Dias, J. A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_49 · Cited by 16
Hoare, S. R. J., Tewson, P. H., Sachdev, S., Connor, M. A., Hughes, T. E., & Quinn, A. M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.814547 · Cited by 15
“The interaction is controlled by the pattern of phosphorylation of the GPCR (the phosphorylation barcode) (Orsini et al., 1999; Oakley et al., 2001; Tobin, 2008; Nobles et al., 2011; Pal et al., 2013; Zhou et al., 2017; Sente et al., 2018; Baidya et al., 2020; DwivediAgnihotri et al., 2020; Latorraca et al., 2020) and…”
Background
Metadata
- Authors
- Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Caron, Marc G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 276
- Issue
- 22
- Pages
- 19452-19460
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2083334427
- Cited by
- 455
- References
- 45
- Citations by year
- 2026: 7 · 2025: 19 · 2024: 8 · 2023: 15 · 2022: 14 · 2021: 13 · 2020: 16 · 2019: 10 · 2018: 11 · 2017: 23 · 2016: 9 · 2015: 9 · 2014: 18 · 2013: 17 · 2012: 19
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl061365-04)
- National Heart, Lung, and Blood Institute (HL61365)
- National Institute of Neurological Disorders and Stroke (NS-19576, R01NS019576)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- beta-arrestin, G protein-coupled receptors, receptor internalization, receptor desensitization, receptor resensitization, serine/threonine phosphorylation, carboxyl-terminal tail, beta2-adrenergic receptor, oxytocin receptor, angiotensin II type 1a receptor, neurokinin-1 receptor, endocytic vesicles
- MeSH terms
- beta-Arrestins, beta-Arrestin 2, Amino Acid Sequence, Cell Line, Cell Membrane, Endocytosis, Humans, Luminescent Proteins, Microscopy, Fluorescence, Molecular Sequence Data, Mutation, Phosphorylation, Plasmids, Protein Binding, Receptors, Angiotensin, Receptors, Cell Surface, Recombinant Fusion Proteins, Time Factors, Transfection, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Receptors, Neurotensin, Receptors, Neurokinin-1, Receptors, Oxytocin, Microscopy, Confocal, Arrestins, Receptor, Angiotensin, Type 1, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review